scholarly journals Clinico-laboratory profile of severe Plasmodium vivax malaria in a tertiary care centre in Kolkata

2013 ◽  
Vol 3 (1) ◽  
pp. 53 ◽  
Author(s):  
Sayantan Ray ◽  
Manjari Saha ◽  
Debojyoti Sarkar ◽  
Arunansu Talukdar ◽  
Amitava Chakraborty
Keyword(s):  
Plasmodium Vivax ◽  
Vivax Malaria ◽  
Tertiary Care ◽  
Care Centre ◽  
Tertiary Care Centre ◽  
Plasmodium Vivax Malaria ◽  
Laboratory Profile

scholarly journals Should we care about Plasmodium vivax and HIV co-infection? A systematic review and a cases series from the Brazilian Amazon

2021 ◽  
Vol 20 (1) ◽  
Author(s):  
Paola López Del-Tejo ◽  
Nadia Cubas-Vega ◽  
Cecilia Caraballo-Guerra ◽  
Bernardo Maia da Silva ◽  
Jefferson da Silva Valente ◽  
...  
Keyword(s):  
Systematic Review ◽  
Plasmodium Vivax ◽  
Vivax Malaria ◽  
Tertiary Care ◽  
Case Series ◽  
Brazilian Amazon ◽  
Outcome Data ◽  
Malaria Episode ◽  
Tertiary Care Centre ◽  
Cross Sectional

Abstract Background Malaria and HIV are two important public health issues. However, evidence on HIV-Plasmodium vivax co-infection (HIV/PvCo) is scarce, with most of the available information related to Plasmodium falciparum on the African continent. It is unclear whether HIV can change the clinical course of vivax malaria and increase the risk of complications. In this study, a systematic review of HIV/PvCo studies was performed, and recent cases from the Brazilian Amazon were included. Methods Medical records from a tertiary care centre in the Western Brazilian Amazon (2009–2018) were reviewed to identify HIV/PvCo hospitalized patients. Demographic, clinical and laboratory characteristics and outcomes are reported. Also, a systematic review of published studies on HIV/PvCo was conducted. Metadata, number of HIV/PvCo cases, demographic, clinical, and outcome data were extracted. Results A total of 1,048 vivax malaria patients were hospitalized in the 10-year period; 21 (2.0%) were HIV/PvCo cases, of which 9 (42.9%) had AIDS-defining illnesses. This was the first malaria episode in 11 (52.4%) patients. Seven (33.3%) patients were unaware of their HIV status and were diagnosed on hospitalization. Severe malaria was diagnosed in 5 (23.8%) patients. One patient died. The systematic review search provided 17 articles (12 cross-sectional or longitudinal studies and 5 case report studies). A higher prevalence of studies involved cases in African and Asian countries (35.3 and 29.4%, respectively), and the prevalence of reported co-infections ranged from 0.1 to 60%. Conclusion Reports of HIV/PvCo are scarce in the literature, with only a few studies describing clinical and laboratory outcomes. Systematic screening for both co-infections is not routinely performed, and therefore the real prevalence of HIV/PvCo is unknown. This study showed a low prevalence of HIV/PvCo despite the high prevalence of malaria and HIV locally. Even though relatively small, this is the largest case series to describe HIV/PvCo.

scholarly journals Clinical and Laboratory Profile of Dengue Fever in Children in a Tertiary Care Centre in Mahabub Nagar, Telangana

2020 ◽  
Vol 7 (15) ◽  
pp. 757-760
Author(s):  
Patta Nagaveni ◽  
Manthena Jagadeesh Kumar ◽  
Kolla Venkata Subbarao ◽  
Anupati Jyothi
Keyword(s):  
Dengue Fever ◽  
Tertiary Care ◽  
Care Centre ◽  
Tertiary Care Centre ◽  
Laboratory Profile

scholarly journals Study various clinical manifestations and biochemical parameter for liver dysfunction in association with Plasmodium vivax malaria

2020 ◽  
Vol 8 (8) ◽  
pp. 3035
Author(s):  
Bajranglal Banthia ◽  
Saad Mohammad Shakir
Keyword(s):  
Plasmodium Vivax ◽  
Liver Dysfunction ◽  
Vivax Malaria ◽  
Tertiary Care ◽  
Clinical Manifestations ◽  
Biochemical Parameter ◽  
Research Centre ◽  
Care Hospital ◽  
Number Of Patients ◽  
Plasmodium Vivax Malaria

Background: Malaria is a parasitic disease which is majorly caused by the bite of an infected Anopheles mosquito. It has been estimated that the most common type of malaria affecting the human race is known as Plasmodium vivax. Human malaria is a global burden with 3.4 billion people at risk over 91 endemic countries. According to the WHO, the involvement of liver dysfunction in Plasmodium vivax malaria is not an uncommon phenomenon. Aim of the research was to study various clinical manifestations and biochemical parameter for liver dysfunction in association with Plasmodium vivax malaria.Methods: It was an observational study carried out at Teerthanker Mahaveer Medical College and Research Centre, a tertiary care hospital situated in Moradabad for a period of 1 year (March 2017-Feb 2018). Total of 200 patients aged above 15 years, with either sex were part of it. All the patients having mixed malaria with dengue, pregnant women and the patients who did not give written consent for being a part of the study were excluded from the study. A detailed clinical examination was done, including all the hematological and biochemical examinations.Results: The results depicted that the number of male patients was 95, and the number of female patients was 105. The majority of the patients belonged to 15-30 years of age group. The major clinical features of the patients suffering from P. Vivax were fever and jaundice. The number of patients with serum bilirubin >3 mg/dl was 55.Conclusions: In light of the above results, it was evident that Plasmodium vivax has the capability of producing jaundice, hepatic dysfunction and anemia. The doctors must be very vigilant while treating the patients with Plasmodium vivax for any symptoms of jaundice as they are often misunderstood as hepatitis.

Sign in / Sign up

Export Citation Format

Share Document